跳至主要内容
临床试验/NCT07372209
NCT07372209已完成不适用

Study of Effects and Underlying Mechanisms of Analgesic Drugs on Inflammatory Pathways and Immune Function in Patients With Endometrial Cancer

Tangshan Maternal and Child Health Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年10月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
blood pressure

研究概览

简要总结

to investigate whether oliceridine is safe and effective for induction of anesthesia by comparing henodynamic changes before and after endotracheal intubation with sufentanil

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 18-65 years;
  • American Society of Anesthesiologists (ASA) physical status I-II;
  • Elective gynecologic laparoscopic surgery;
  • Expected operative time 60-180 minutes;

排除标准

  • Severe cardiovascular instability (e.g., acute decompensated heart failure, acute myocardial infarction, or life-threatening arrhythmia);
  • Uncontrolled hypertension;
  • Severe renal or hepatic dysfunction;
  • Severe mental disorder or psychiatric illness;
  • Known allergy or hypersensitivity to opioids;
  • History of alcohol abuse or opioid addiction;
  • Anticipated difficult airway;
  • Pregnancy or lactation;

研究组 & 干预措施

sufentanil

Active Comparator

0.5μg/kg of sufentanil was used for anesthesia induction

干预措施: Sufentanil (Drug)

Oliceridine

Experimental

0.13mg/kg oliceridine was used for anesthesia induction

干预措施: Oliceridine (Drug)

结局指标

主要结局

blood pressure

时间窗: baseline, at the moment of intubation, right after intubation, 1 minute、3 minutes, and 5 minutes after intubation

heart beat

时间窗: baseline, at the moment of intubation, right after intubation, 1 minute、3 minutes, and 5 minutes after intubation

次要结局

  • adverse reactions(from the administration of sufentanil or oliceridine until discharge from the post-anesthesia care unit (PACU))

研究者

发起方
Tangshan Maternal and Child Health Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yu Zhang

principle nvestigator

Tangshan Maternal and Child Health Hospital

研究点 (1)

Loading locations...

相似试验